Latest News about KURE
Recent news which mentions KURE
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
August 01, 2025
From Benzinga
From Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
From Benzinga
From Benzinga
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
From Benzinga
3 Thematic China ETFs for An Uncertain Outlook
February 26, 2024
From ETF Trends
Crackdown on China Healthcare Corruption Could Help This ETF
December 07, 2023
Tickers
KURE
From ETF Trends
Innovation Alongside Recovery Can Boost These China ETFs
November 13, 2023
From ETF Trends
China Agrees to Global Collaboration on Artificial Intelligence
November 06, 2023
From ETF Trends
China Sits Firmly Atop Global Innovation Index
September 22, 2023
From ETF Trends
China’s Government Can Help Propel This Innovation ETF
August 15, 2023
From ETF Trends
China Looks to Bolster Economy With Fewer Travel Restrictions
August 08, 2023
From ETF Trends
From ETF Trends
China Growth Outlook Could Boost This ETF in 2023
January 11, 2023
From ETF Trends
Foreign Investors Flooding Back into China
January 05, 2023
From ETF Trends
Why China’s Healthcare Sector Might be the Real Reopening Play
December 07, 2022
From ETF Trends
KURE Could Be Interesting Play Following China Party Congress
October 19, 2022
Tickers
KURE
From ETF Trends
China Stocks Look Set For A Rebound, Morgan Stanley Quant Strategists Say
September 13, 2022
From Benzinga
This Week’s Top Performing ETFs: 06/19/2022
June 22, 2022
From ETF Trends
From ETF Trends
The Olympics Highlight Innovations in China, Invest With KGRO
February 03, 2022
From ETF Trends
KraneShares Launches New ETF Focused on China’s High Growth Sectors
October 07, 2021
From ETF Trends